Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma

Marqibo, a sphingosomal/cholesterol encapsulation of vincristine sulfate has targeted, increased, and sustained delivery of vincristine to tumor tissues. A phase 2, open‐label, single‐arm, and multinational study evaluated the efficacy and tolerability of Marqibo as a single agent in patients with multiply relapsed or refractory aggressive non‐Hodgkin lymphoma (NHL).

[1]  J. Connors,et al.  A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma , 2002, Leukemia & lymphoma.

[2]  L. Mayer,et al.  Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. , 2001, The Journal of pharmacology and experimental therapeutics.

[3]  K. Wood,et al.  Past and future of the mitotic spindle as an oncology target. , 2001, Current opinion in pharmacology.

[4]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Bally,et al.  Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. , 1995, British Journal of Cancer.

[6]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[7]  F. Cabanillas,et al.  Sphingosomal vincristine in CHOP is a promising new treatment for elderly, as well as poor prognosis patients with aggressive non-Hodgkin's lymphoma (NHL): Follow-up results of a phase II study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. E. Gidding,et al.  Vincristine revisited. , 1999, Critical reviews in oncology/hematology.

[9]  K. Gelmon,et al.  Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer , 1998, Cancer Chemotherapy and Pharmacology.

[10]  H. Niitani,et al.  [Antimicrotubule agents]. , 1993, Gan to kagaku ryoho. Cancer & chemotherapy.

[11]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .